Fundraising FoxDiasome Pharmaceuticals
Cleveland, US · Delaware corporation · 2 known investors
Find your way into Diasome Pharmaceuticals
Sign up to see every warm intro you have to Diasome Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diasome Pharmaceuticals team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RG
Robert GehoCo-founder
WB
W. Blair GehoCo-founder
HK
Helga KautskyExecutive
Board
MO
GZ
Guiseppe ZoccoBoard director
RC
Richard CarusoBoard director
PT
Peter TollmanBoard director
FM
Frank McCaneyBoard director
TM
Thomas McDonaldBoard director
CO
Cosme OrdonezBoard director
Investors · 2
JDRF T1D FundreportedBoston
How we know: funding news · press coverage · Not right? Tell us
MedicxireportedLondon
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$49.6M disclosed across 7 rounds · 2016–2024
▶$3.1MraisedAug 2024 · 4 investors · Other Health CareRule 506(b)
▶$3.1MraisedAug 2024 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter TollmanDirector
- Robert GehoExecutive Officer, Director
- Frank McCaneyDirector
- W. Blair GehoExecutive Officer, Director
- Thomas McDonaldDirector
- Cosme OrdonezDirector
- Offering amount
- $15.6M
- Amount sold
- $3.1M
- Finders' fees
- $152.1K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedJun 2023 · 2 investors · OtherRule 506(b)
▶$9MraisedJun 2023 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thomas McDonaldDirector
- Peter TollmanDirector
- Robert GehoExecutive Officer, Director
- Marc PennDirector
- Frank McCaneyDirector
- W. Blair GehoDirector
- Offering amount
- $15M
- Amount sold
- $9M
- Finders' fees
- $350K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.7MraisedSep 2022 · 40 investors · BiotechnologyRule 506(b)
▶$16.7MraisedSep 2022 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marc PennDirector
- Robert GehoExecutive Officer, Director, Promoter
- Thomas McDonaldDirector
- W. Blair GehoDirector
- Frank McCaneyDirector
- Offering amount
- $19.1M
- Amount sold
- $16.7M
- Finders' fees
- $537.7K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedDec 2020 · 6 investors · BiotechnologyRule 506(b)
▶$1.5MraisedDec 2020 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GehoExecutive Officer, Director, Promoter
- Marc PennDirector
- Frank McCaneyDirector
- W. Blair GehoDirector
- Thomas McDonaldDirector
- Offering amount
- $5M
- Amount sold
- $1.5M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedApr 2020 · 20 investors · BiotechnologyRule 506(b)
▶$2.9MraisedApr 2020 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marc PennDirector
- Robert GehoExecutive Officer, Director, Promoter
- W. Blair GehoDirector
- Frank McCaneyDirector
- Thomas McDonaldDirector
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.1MraisedOct 2018 · 22 investors · BiotechnologyRule 506(b)
▶$12.1MraisedOct 2018 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GehoExecutive Officer, Director
- Thomas McDonaldDirector
- Marc PennDirector
- Frank McCaneyDirector
- W. Blair GehoDirector
- Offering amount
- $18.6M
- Amount sold
- $12.1M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedJan 2017 · 4 investors · PharmaceuticalsRule 506(b)
▶$4.3MraisedJan 2017 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michele OllierDirector
- Thomas McDonaldDirector
- Helga KautskyExecutive Officer
- Frank McCaneyDirector
- Robert GehoExecutive Officer, Director
- Guiseppe ZoccoDirector
- W. Blair GehoDirector
- Richard CarusoDirector
- Offering amount
- $8M
- Amount sold
- $4.3M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Diasome Pharmaceuticals?
- Diasome Pharmaceuticals was founded by Robert Geho, W. Blair Geho.
- Who are Diasome Pharmaceuticals's investors?
- Diasome Pharmaceuticals's investors include JDRF T1D Fund, Medicxi.
- How much funding has Diasome Pharmaceuticals raised?
- Diasome Pharmaceuticals has disclosed $49.6M raised across 7 rounds.
- Where is Diasome Pharmaceuticals headquartered?
- Diasome Pharmaceuticals is headquartered in Cleveland, US.